CT1-DAP001

· University of California, San Diego

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for CT1-DAP001, covering 2025-01-29 to 2025-01-29. Get the full timeline:

Most recent: Clinical Trial Update: Transplantation of Human iPS Cell-derived Dopaminergic Progenitors (CT1-DAP001) for Parkinson's Disease (Phase I/II) [Phase 1]

See pricing